Search filters

List of works by Ryuichi Noguchi

A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma.

scientific article published on May 2012

A histologically proven case of progressive liver sarcoidosis with variceal rupture ⬇️

scientific article published on October 27, 2011

A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats.

scientific article published on 22 May 2006

Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.

scientific article published on January 2006

Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.

scientific article published on May 2006

Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice.

scientific article published on 20 July 2005

Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy.

scientific article

Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development

scientific article published on 17 August 2006

Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development

scientific article published on 01 September 2003

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

scientific article

Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats.

scientific article published on 26 November 2009

Balloon catheter-assisted endoscopic sclerotherapy for gastric fundal varices using alpha-cyanoacrylate monomer.

scientific article published on July 2001

Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.

scientific article published on 21 July 2015

Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats.

scientific article

Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance ⬇️

scientific article published on May 27, 2013

Cecal Tuberculosis Mimicking Submucosal Tumor

scientific article published on 15 July 2016

Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.

scientific article published on 23 March 2011

Combination of branched-chain amino acid and angiotensin-converting enzyme inhibitor improves liver fibrosis progression in patients with cirrhosis.

scientific article published on 15 November 2011

Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial.

scientific article published on 24 August 2011

Combination of copper-chelating agent, trientine, and methotrexate attenuates colorectal carcinoma development and angiogenesis in mice.

scientific article published on July 2005

Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice.

scientific article published in March 2005

Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.

scientific article published in February 2005

Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.

scientific article published on December 2003

Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis.

scientific article

Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.

scientific article

Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression

scientific article

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

scientific article published on 28 December 2016

Cross talk between toll‐like receptor‐4 signaling and angiotensin‐II in liver fibrosis development in the rat model of non‐alcoholic steatohepatitis ⬇️

scientific article published on April 1, 2013

Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis

scientific article

Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats.

scientific article published in November 2007

DNA methylation of angiotensin II receptor gene in nonalcoholic steatohepatitis-related liver fibrosis

scientific article published on October 2016

Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report.

scientific article published on 7 January 2009

Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development

scientific article published on 01 May 2005

Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization

scientific article published on 01 January 2008

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats ⬇️

scientific article published on March 12, 2013

Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model.

scientific article published on 28 February 2013

Dual blockade of angiotensin-II and aldosterone suppresses the progression of a non-diabetic rat model of steatohepatitis.

scientific article published on 20 November 2012

Gastric adenocarcinoma of fundic gland type (chief cell predominant type) with unique endoscopic appearance curatively treated by endoscopic submucosal resection

scientific article published on July 2015

Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.

scientific article

Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.

scientific article published on 23 December 2004

Impact of insulin resistance on the progression of chronic liver diseases.

scientific article published in December 2008

Impact of renin-angiotensin system in hepatocellular carcinoma.

scientific article published on May 2011

Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.

scientific article

Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development.

scientific article published in July 2004

Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.

scientific article

Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.

scientific article

Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis

scientific article published on 21 July 2016

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat.

scientific article

Magnetic resonance angiography for monitoring prophylactic endoscopic treatment of high risk esophageal varices

scientific article published on 01 October 2000

Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis

scientific article published on 01 July 2008

Periostin cross‑reacts with the renin‑angiotensin system during liver fibrosis development.

scientific article published on 24 August 2017

Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance

scientific article published on 01 April 2000

Possible involvement of angiogenesis in chronic liver diseases: interaction among renin-angiotensin-aldosterone system, insulin resistance and oxidative stress.

scientific article published on January 2012

Predictive parameter of tolvaptan effectiveness in cirrhotic ascites

scientific article

Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization

scientific article published on 28 June 2017

Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group

scientific article published on 01 April 1999

Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.

scientific article

Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats.

scientific article published on 23 September 2005

Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report ⬇️

scientific article published on March 29, 2011

Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats

scientific article published on September 1, 2010

Selective aldosterone blocker, eplerenone, attenuates hepatocellular carcinoma growth and angiogenesis in mice.

scientific article

Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.

scientific article published on September 2017

Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells.

scientific article

Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.

scientific article published on February 2007

Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via anti-angiogenic activities.

scientific article

The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells.

scientific article published on December 2001

The effect of inflammatory cytokines in alcoholic liver disease.

scientific article published on 09 December 2013

The selective control of glycolysis, gluconeogenesis and glycogenesis by temporal insulin patterns.

scientific article published on 14 May 2013

The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure.

scientific article published on 24 August 2010

The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model

scientific article published on 01 April 2001

Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model

scientific article published on 01 June 2003

Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model

scientific article published on 01 December 2000

Tuberculous peritonitis during pegylated interferon plus ribavirin combination therapy in a patient with chronic hepatitis C.

scientific article published on December 2014

[Primary cardiac leiomyosarcoma originating from the left atrium]

scientific article published on 01 November 2012

[Series: Diagnosis at a glance]

scientific article published on 01 October 2011

Paulina is supported by:

About Paulina

Help